Quadrature Capital’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Other funds holding SLDB
SL
Quadrature Capital's SLDB Position: Q3 2026 in Review
Quadrature Capital reduced its Solid Biosciences (SLDB) stake by 63% in Q3 2026, selling an estimated $448K and leaving 28,817 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.
Quadrature Capital first reported a position in SLDB in Q1 2025 and has held it in 3 quarters since. The position peaked at $782K in Q2 2026. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.
- Quadrature Capital held 28,817 shares of Solid Biosciences worth $208K as of Q3 2026.
- Quadrature Capital sold 49,473 Solid Biosciences shares in Q3 2026, an estimated $448K.
- Solid Biosciences made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1762 holding.
- Quadrature Capital first reported a position in Solid Biosciences in Q1 2025 and has held it in 3 quarters since.
- Quadrature Capital's Solid Biosciences position peaked at $782K in Q2 2026.
- 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.
Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.